29% increase in Twirla cycles27% increase in total prescriptions (TRx) of Twirla PRINCETON, N.J., April 14, 2022– Agile Therapeutics, Inc. (NASDAQ: AGRX), a women’s healthcare company, today announced Twirla prescription data for the first quarter … Continue reading Agile Therapeutics (NASDAQ: AGRX) Announces First Quarter 2022 Prescription Data for Twirla®